TCL Archive Genentech: ODAC Lacks Expertise, Impartiality; FDA: Company’s Proposal Unscientific August 12, 2011
TCL Archive Intarferon Results Promising, ACS Says, And commits Another $3.4 Million February 22, 1980
TCL Archive U.S., Canada Begin ExCel Trial To Evaluate Aromasin For Breast Cancer Prevention April 29, 2005